Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human FSH vs follitropin alfa in controlled ovarian stimulation for ART
CTR20171142Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human follicle stimulating hormone in female infertility, sponsored by Ferring Pharmaceuticals. Started Dec 2017; status: completed.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20171142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171142.